Target intelligence / Profile preview

Envelope Glycoprotein GP120 (gp120)

Target
gp120
Molecular classification
Glycoprotein, Viral Envelope Protein
01

Overview

Envelope glycoprotein GP120 is a surface-exposed glycoprotein of the Human Immunodeficiency Virus (HIV), essential for viral entry into host cells. It mediates HIV's initial interaction with host cells through sequential binding to CD4 receptors and chemokine coreceptors (primarily CCR5 or CXCR4), leading to membrane fusion. Gp120 is a major target for neutralizing antibodies, but its extensive sequence variability, glycan shielding, and conformational flexibility pose significant challenges for vaccine development.

Other names
HIV-1 gp120GP120 envelope protein
02

Mechanism of action

Target for neutralizing antibodies; inhibits viral entry.

03

Biological functions

Viral entry into host cellsCD4 receptor bindingCoreceptor binding (CCR5, CXCR4)Membrane fusion
04

Disease associations

HIV infectionAIDS pathogenesis
05

Safety considerations

High sequence variabilityGlycan shieldingElicitation of non-neutralizing antibodiesConformational flexibility hindering vaccine design

Beyond the preview

Go deeper on Envelope Glycoprotein GP120 (gp120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope Glycoprotein GP120 (gp120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call